UTHR

United Therapeutics's NDA for inhaled treprostinil accepted for FDA review - 09/04 - 10:58 AM ET

Inhaled Treprostinil New Drug Application Filed by FDA - 09/03 - 11:44 AM ET

United Therapeutics (UTHR) - 08/27 - 07:10 AM ET

United Therapeutics Challenges Support On Increased Volume - 08/21 - 12:33 PM ET

United Therapeutics Set New High for Year Thursday - 08/01 - 08:10 AM ET

UTHR: Q2 Earnings Call @ 09:00 ET Today [delayed] - 07/31 - 07:34 AM ET

United Therapeutics Reports Second Quarter 2008 Financial Results - 07/31 - 07:00 AM ET

United Therapeutics Breaks Resistance, Hits 7-Month High - 07/17 - 11:21 AM ET

United Therapeutics Sets Seven Month High - 07/03 - 08:06 AM ET

United Therapeutics submits new drug application for inhaled treprostinil to FDA - 06/30 - 07:26 AM ET

New Drug Application for Inhaled Treprostinil Submitted to the U.S. Food and Drug Administration - 06/30 - 07:00 AM ET

United Therapeutics Corporation (UTHR) Corporate Event Announcement Notice - 06/25 - 09:07 PM ET

United Therapeutics Corporation (UTHR) Corporate Event Announcement Notice - 06/24 - 09:07 PM ET

United Therapeutics Sets Four Month Closing High - 05/28 - 07:49 AM ET

Treprostinil Data Presented at American Thoracic Society Conference Demonstrates Significant Clinical Progress in All Four Routes of Administration - 05/21 - 04:00 PM ET

Treprostinil Data to be Presented at Annual Meeting of the American Thoracic Society - 05/06 - 07:00 AM ET

United Therapeutics Reveals Results Of 2008 Annual Meeting Of Shareholders - 05/01 - 05:21 PM ET

United Therapeutics Announces the Results of Its 2008 Annual Meeting of Shareholders - 05/01 - 05:00 PM ET

United Therapeutics Swings To Profit In Q1 On Strong Top Line Growth And Lower R&D Costs - 05/01 - 03:23 PM ET

United Therapeutics Swings To Profit In Q1 - 05/01 - 09:14 AM ET

Page 1 of 5     1  2   3   4   5      Previous  |  Next

<< Back to Stock Index